Trial intelligence / Profile preview

Fenofibrate vs Niacin/Laropiprant in T2D with Low HDL

NCT02153879Phase 4Completed

Sponsor
Institut d'Investigació Sanitària Pere Virgili
Start
Feb 2009
Primary completion
Dec 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of fenofibrate, niacin, laropiprant in dyslipidemia, sponsored by Institut d'Investigació Sanitària Pere Virgili. Started Feb 2009; status: completed.

02

Drugs

fenofibrateniacinlaropiprant
03

Conditions

dyslipidemia

Beyond the preview

Go deeper on NCT02153879.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02153879.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call